During the past decade, Zorgsaam Ziekenhuis conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zorgsaam Ziekenhuis" #1 sponsor was "Erasmus Medical Center" with 2 trials, followed by "The Netherlands Cancer Institute" with 2 trials sponsored, "Association NVALT Studies" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "German CLL Study Group" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zorgsaam Ziekenhuis" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Dutch Colorectal Cancer Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Zorgsaam Ziekenhuis" are "Adjuvant Therapy" (1 trials), "Advanced Breast Cancer" (1 trials), "Anemia" (1 trials), "Breast Cancer" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Zorgsaam Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Zorgsaam Ziekenhuis" are "Drug" (8 trials), "Biological" (3 trials), "Radiation" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Acetylsalicylic acid" (1 trials), "Alpelisib" (1 trials), "Bendamustine" (1 trials) and "Cabazitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zorgsaam Ziekenhuis" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Zorgsaam Ziekenhuis". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Zorgsaam Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Zorgsaam Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".